- Topic
20k Popularity
12k Popularity
98k Popularity
2k Popularity
8k Popularity
- Pin
- 📢 Exclusive on Gate Square — #PROVE Creative Contest# is Now Live!
CandyDrop × Succinct (PROVE) — Trade to share 200,000 PROVE 👉 https://www.gate.com/announcements/article/46469
Futures Lucky Draw Challenge: Guaranteed 1 PROVE Airdrop per User 👉 https://www.gate.com/announcements/article/46491
🎁 Endless creativity · Rewards keep coming — Post to share 300 PROVE!
📅 Event PeriodAugust 12, 2025, 04:00 – August 17, 2025, 16:00 UTC
📌 How to Participate
1.Publish original content on Gate Square related to PROVE or the above activities (minimum 100 words; any format: analysis, tutorial, creativ - 💙 Gate Square #Gate Blue Challenge# 💙
Show your limitless creativity with Gate Blue!
📅 Event Period
August 11 – 20, 2025
🎯 How to Participate
1. Post your original creation (image / video / hand-drawn art / digital work, etc.) on Gate Square, incorporating Gate’s brand blue or the Gate logo.
2. Include the hashtag #Gate Blue Challenge# in your post title or content.
3. Add a short blessing or message for Gate in your content (e.g., “Wishing Gate Exchange continued success — may the blue shine forever!”).
4. Submissions must be original and comply with community guidelines. Plagiarism or re - 🎉 The #CandyDrop Futures Challenge# is live — join now to share a 6 BTC prize pool!
📢 Post your futures trading experience on Gate Square with the event hashtag — $25 × 20 rewards are waiting!
🎁 $500 in futures trial vouchers up for grabs — 20 standout posts will win!
📅 Event Period: August 1, 2025, 15:00 – August 15, 2025, 19:00 (UTC+8)
👉 Event Link: https://www.gate.com/candy-drop/detail/BTC-98
Dare to trade. Dare to win.
Overview of VitaDAO's Multi-Domain Anti-Aging Research Projects with Huge Potential
A Review of High Application Potential Cases of Funded Projects in VitaDAO
VitaDAO has funded multiple projects with high application potential, covering various fields such as autophagy activators, Alzheimer's disease diagnostics, RNA therapies, and cardiovascular disease treatments. Here are some representative cases:
VDP-16: Korolchuk Laboratory - Autophagy Activator
The project aims to discover new autophagy activators by screening a library of natural compounds to combat aging and related diseases. Autophagy is the process by which cells eliminate damaged components, and its function diminishes during the aging process. The project employs a high-throughput screening system to quickly identify true autophagy activators. Once autophagy activators are transformed into health products that resist aging, the commercial prospects are broad.
VDP-17: Cooperation with Crowd Funded Cures
The project aims to re-screen 20,000 generic drugs that have obtained FDA approval in the market, some of which have expired patents or are no longer maintained. Reutilizing existing expired patented drugs can significantly reduce the cost and time of developing new drugs and accelerate the上市进程.
VDP-32: Hyperspectral Imaging Device for Early Diagnosis of Alzheimer's Disease
Mantis Photonics is developing a transistor camera for retinal imaging to enable early screening for Alzheimer's disease. This camera can be mounted on conventional retinal imagers, and the expected cost will be far lower than existing products on the market, helping to drive widespread adoption.
VDP-89: ExcepGen Inc - RNA Therapy for Longevity
ExcepGen Inc is developing an RNA therapeutic platform called RNAx, aimed at enhancing the efficacy of RNA vaccines by optimizing RNA delivery and regulating cellular signals, particularly against hard-to-target antigens like the universal influenza virus.
VDP-112: Cyclarity - A novel cyclodextrin molecule for various aging-related diseases
Cyclarity Therapeutics is developing a cyclodextrin capsule drug that can extract harmful biomolecules accumulated during aging from cells and tissues. Its primary drug target is oxidized cholesterol, which is a significant factor in various age-related diseases.
VDP-120: Oisín Biotechnologies - Gene therapeutics for health and longevity
Oisín Biotechnologies focuses on developing gene medicine solutions to treat age-related diseases, and its technology platform is capable of effectively delivering specific DNA and RNA to treat age-related diseases such as muscle atrophy.
These projects cover multiple stages from early diagnosis to treatment, with broad application prospects and market potential. As the global population continues to age, these research findings are expected to make significant contributions to healthy aging.